Duane Rowe
Optometrist · Hilo, HINPI 1295824704
Payments from drug & device makers
What this record shows
10 manufacturers reported payments, led by Bausch & Lomb, A Division Of Bausch Health US, LLC at 55.5% of the total. Reporting peaked in 2019 at $3,345 and has fallen 80.8% since, to $641 in 2025.
Across 48 payments — averaging $120.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb, A Division Of Bausch Health US, LLC$3K
- Bausch & Lomb Americas Inc.$629
- Alcon$565
- Johnson & Johnson Vision Care, Inc.$409
- Amgen$295
- AbbVie$279
- plus $397 from 4 others
What the payments were for
- Travel & lodging$3,02152%
- Food & beverage$2,76748%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 10 | $3,214 |
| Bausch & Lomb Americas Inc. | 7 | $629 |
| Alcon | 6 | $565 |
| Johnson & Johnson Vision Care, Inc. | 14 | $409 |
| Amgen(2 entities) | 3 | $295 |
| AbbVie | 3 | $279 |
| Sight Sciences, Inc. | 2 | $168 |
| Tarsus Pharmaceuticals, Inc. | 1 | $125 |
| Shire North American Group Inc | 1 | $73 |
| Optos, Inc. | 1 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ULTRA$2,821
- BIOTRUE$2,717
- Hydrus Microstent$283
- INFUSE$208
- BIOTRUE ONE DAY$208
- Voyager DSLT$148
- Clareon$146
- OMNI$125
- XDEMVY$125
- TEPEZZA$125
How this compares
$5,789 in reported general payments places this provider in the 85th percentile of 310 optometrist providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 50 | $518 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 13 | $211 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Hilo
- Grant MiyashiroHilo$26K
- Jana SouzaHilo$16K
- Cedric MitsuiHilo$4K
- Geoffrey ReynoldsMililani$14K
- Jon IshiharaWaipahu$13K
- Patricia IchimuraHonolulu$11K
- Lillian TakamuraHonolulu$11K
- Carlene Ozaki MorishigeAiea$10K
- Cherilyn LaiHonolulu$10K
- Kari Chang MosesKaneohe$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.